Cargando…
High dose intravenous colistin methanesulfonate therapy is associated with high rates of nephrotoxicity; a prospective cohort study from Saudi Arabia
BACKGROUND: Nephrotoxicity is an important adverse effect of colistin methanesulfonate (CMS) therapy. No data exist on rates and risk factors for colistin-related nephrotoxicity in Saudi Arabia (SA). We conducted a prospective cohort study to identify rates and risk factors for CMS nephrotoxicity in...
Autores principales: | Omrani, Ali S, Alfahad, Wafa A, Shoukri, Mohamed M, Baadani, Abeer M, Aldalbahi, Sultan, Almitwazi, Ali A, Albarrak, Ali M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4301664/ https://www.ncbi.nlm.nih.gov/pubmed/25591721 http://dx.doi.org/10.1186/s12941-015-0062-8 |
Ejemplares similares
-
Physicians’ knowledge, perceptions, and attitudes toward antimicrobial prescribing in Riyadh, Saudi Arabia
por: Baadani, Abeer M., et al.
Publicado: (2015) -
The risk factors of colistin methanesulfonate associated nephrotoxicity
por: Tigen, Elif Tükenmez, et al.
Publicado: (2016) -
Risk factors for acute kidney injury in critically ill patients receiving high intravenous doses of colistin methanesulfonate and/or other nephrotoxic antibiotics: a retrospective cohort study
por: Rocco, Monica, et al.
Publicado: (2013) -
The clinical outcome of HIV infection at a tertiary care center in Riyadh, Saudi Arabia
por: Baadani, Abeer M., et al.
Publicado: (2020) -
Vancomycin therapy in critically ill patients on continuous renal replacement therapy; are we doing enough?
por: Omrani, Ali S., et al.
Publicado: (2015)